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background:  So called “single-shot” ablation devices like the novel ablation catheter with 10 irrigated ablation electrodes (nMARQ) 
integrated into the CARTO electro-anatomic mapping system have entered the every-day practice of atrial fibrillation (AF) ablation. We 
present our single-center experience on consecutive patients undergoing AF ablation using the nMARQ catheter. 
Methods:  Consecutive patients undergoing left atrial ablation to treat AF using the nMARQ catheter were prospectively included. Ablations 
were directed towards effective pulmonary vein isolation using different energy settings (group 1:maximum 25Watts at posterior wall, group 
2:maximum 20Watts at posterior wall, group 3:maximum 20 Watts at posterior wall with automated software adoption (PRA) to further 
optimized energy application) addressed to increase acute safety and efficacy. In group 4 (maximum 20W at posterior wall with PRA) no 
esophageal temperature probe to monitore esophageal temperature was used. All patients eligible underwent post-ablation endoscopicy 
to detect asymptomatic thermal esophageal damage (EDELs) and MRI of the brain to detect asymptomatic cerebral events (SCE) was 
performed. 
results:  139 patients (45% persistent AF) were included (mean procedure duration 117±36min, ablation duration 19±7min). Overall SCE 
were identified in 23% (26/115) and EDEL in 21% (29/139) of all patients. SCE were identified in 32% of group 1, 29% of group 2, 18% 
of group 3 and 12% of group 4 patients. EDEL were documented in 44% of group 1, 20% of group 2, 25% of group 3 and 0% of group 4 
patients. 1 atrio-esophageal fistula in group 1, 1 persistent phrenic nerve palsy (group 2) and 1 femoral pseudoaneurysm (group 4) were 
identified. 12-month rhythm follow-up identified stable sinus rhythmus off antiarrhythmics in 31 out of 41 eligible patients (76%). 
Conclusion:  AF ablation using thenMARQ appears to be safe and effective in stabilizing sinus rhythm in 76% of patients. EDEL appear 
to be related to the usage of an esophageal temperature probe and the maximum energy applied at the posterior wall. Incidence of MRI 
detected SCE may be related to the delivered energy protocol and periprocedural anticoagulation regimen.
